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BOOK REVIEW
The Cell Builders. H. Garrett DeYoung. 1986.
Doubleday, New York. 227 p. $16.95 hardcover.
The Cell Builders has something for everyone. A rivet-
ing account of the conception, birth, and development of
monoclonal antibody, anti-cancer therapy, it is also three
intricately woven threads that reflect the multidimen-
sional fabric of the still-fledgling field of biotechnology.
For the lover of romance and drama, The Cell Builders
is the story of Jack Christie, a physician who suddenly
finds himself a patient in the clutches of lymphoma. As
Christie struggles to accept and understand and ulti-
mately fight his disease, the reader becomes personally a
part of his battle — one that taps into the latest bio-
technological tools as monoclonals are developed against
his cancer cells. Through Jack's eyes, we see a cancer's
effects on personality, lifestyle, and relationships, a tell-
ing contrast to the clinical, microscopic view of the errant
cells seen through the eyes of researchers in other parts of
the book.
Throughout The Cell Builders, DeYoung deftly delivers
lessons in immunology, genetics, and cell biology as
Christie and his wife leaf through medical journals, or
as the author himself tours the facilities that pro-
vide Christie with his hopeful "magic bullets." The au-
thor, a chemist by training, brings to the narrative a
unique perspective, because as a senior editor at High
Technology magazine, he has personally witnessed the
debut and growth of the biotechnology industry from
an insider's perch.
In parallel to Christie's tale is the accurate portrayal of
research at all levels, from Kohler and Milstein's Nobel-
prizewinning work on monoclonals ("It was so simple,
yet so grand, that he couldn't understand why no one had
thought of it before."), to eager young post-docs and
Ph.D.s carving their niches in the unanticipated smor-
gasbord of new biotech companies, to a talented research
assistant with an uncanny ability to make any cell in her
care grow. DeYoung shows us the camaradarie and com-
petition, the slave labor and serendipity, that is science.
The business-minded will not be disappointed either,
for the third thread chronicles the evolution of Damon
Biotech, one of the first companies to tap innovative
biological research and attempt to apply it to the health
care industry — specifically, the scale-up and delivery of
monoclonal antibodies. The government's role in devel-
oping the technology is also perused. Gradually, the
doings at Damon, the National Cancer Institute, and
Christie's search for a cure converge, with a surprise
ending.
The Cell Builders will mean different things to different
people. For the scientist or scientist-to-be, it is a highly
entertaining "you are there" summary of a medical mile-
stone, one we are surely to hear more about. Christie's
fight against cancer as a backdrop against the devel-
opment of monoclonal antibody therapy offers a human
perspective sometimes overshadowed in the laboratory.
For the layperson, however, the sidetrips into lympho-
cyte interactions and the intricacies of genetic engineer-
ing and cell culture may be rough-going — despite the
considerable writing skills of the author.
But the unusual mix of science and storytelling that
distinguishes The Cell Builders from other popular science
books makes it ideal for the college student — par-
ticularly one intimidated by science. For interspersed be-
tween Christie's private battle against his ravaged body
and the intrigues of corporate biotechnology and the
government research system can be found some of the
clearest and most exciting descriptions anywhere of the
basic biology behind immunotherapy, genetic engineer-
ing, cancer cell biology, and, perhaps most importantly,
of how science is conducted.
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